Sepantronium Bromide for the Treatment of High-grade B-cell Lymphoma

NCT05263583 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

High-grade B-cell Lymphoma
Burkitt Lymphoma
Lymphoma, B-Cell
Lymphoma, Large B-Cell, Diffuse
Lymphatic Diseases
Lymphoma, High-Grade
C-MYC/BCL2 Double-Hit High-Grade B-Cell Lymphoma
C-MYC/BCL6 Double-Hit High-Grade B-Cell Lymphoma
C-Myc Gene Rearrangement

Interventions

DRUG: Sepantronium Bromide

Sponsor

Cothera Bioscience, Inc